These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

948 related articles for article (PubMed ID: 34685679)

  • 1. A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment.
    Hofer F; Di Sario G; Musiu C; Sartoris S; De Sanctis F; Ugel S
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Regulation of Myeloid-Derived Suppressor Cell Function in Cancer.
    Wang Y; Jia A; Bi Y; Wang Y; Liu G
    Cells; 2020 Apr; 9(4):. PubMed ID: 32325683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor.
    Yan D; Adeshakin AO; Xu M; Afolabi LO; Zhang G; Chen YH; Wan X
    Front Immunol; 2019; 10():1399. PubMed ID: 31275326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression.
    Groth C; Hu X; Weber R; Fleming V; Altevogt P; Utikal J; Umansky V
    Br J Cancer; 2019 Jan; 120(1):16-25. PubMed ID: 30413826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connections between Metabolism and Epigenetic Modification in MDSCs.
    Dai H; Xu H; Wang S; Ma J
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment.
    Mi Y; Guo N; Luan J; Cheng J; Hu Z; Jiang P; Jin W; Gao X
    Front Immunol; 2020; 11():737. PubMed ID: 32391020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of myeloid derived suppressor cells in cancer from a biomarker perspective.
    Kalathil SG; Thanavala Y
    Cell Immunol; 2021 Mar; 361():104280. PubMed ID: 33445053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Reprogramming of Myeloid-derived Suppressor Cells in the Tumor Microenvironment.
    Liu L; Huo S; Liu J; Li Q; Wang J
    Discov Med; 2021; 31(164):141-146. PubMed ID: 35188888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment.
    Qu P; Wang LZ; Lin PC
    Cancer Lett; 2016 Sep; 380(1):253-6. PubMed ID: 26519756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy.
    Zalfa C; Paust S
    Front Immunol; 2021; 12():633205. PubMed ID: 34025641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.
    De Cicco P; Ercolano G; Ianaro A
    Front Immunol; 2020; 11():1680. PubMed ID: 32849585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic reprogramming of myeloid-derived suppressor cells: An innovative approach confronting challenges.
    Li X; Li Y; Yu Q; Qian P; Huang H; Lin Y
    J Leukoc Biol; 2021 Aug; 110(2):257-270. PubMed ID: 34075637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging.
    Salminen A; Kauppinen A; Kaarniranta K
    J Mol Med (Berl); 2019 Aug; 97(8):1049-1064. PubMed ID: 31129755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy metabolism manipulates the fate and function of tumour myeloid-derived suppressor cells.
    Hu C; Pang B; Lin G; Zhen Y; Yi H
    Br J Cancer; 2020 Jan; 122(1):23-29. PubMed ID: 31819182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical immunosuppressive effect of MDSC‑derived exosomes in the tumor microenvironment.
    Rashid MH; Borin TF; Ara R; Piranlioglu R; Achyut BR; Korkaya H; Liu Y; Arbab AS
    Oncol Rep; 2021 Mar; 45(3):1171-1181. PubMed ID: 33469683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment.
    Schafer CC; Wang Y; Hough KP; Sawant A; Grant SC; Thannickal VJ; Zmijewski J; Ponnazhagan S; Deshane JS
    Oncotarget; 2016 Nov; 7(46):75407-75424. PubMed ID: 27705910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs.
    Cresswell GM; Wang B; Kischuk EM; Broman MM; Alfar RA; Vickman RE; Dimitrov DS; Kularatne SA; Sundaram CP; Singhal S; Eruslanov EB; Crist SA; Elzey BD; Ratliff TL; Low PS
    Cancer Res; 2021 Feb; 81(3):671-684. PubMed ID: 33203700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of microRNAs on myeloid-derived suppressor cells in cancer.
    Baghbani E; Noorolyai S; Duijf PHG; Silvestris N; Kolahian S; Hashemzadeh S; Baghbanzadeh Kojabad A; FallahVazirabad A; Baradaran B
    Hum Immunol; 2021 Sep; 82(9):668-678. PubMed ID: 34020831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-mesenchymal transition: When tumor cells meet myeloid-derived suppressor cells.
    Cai J; Cui Y; Yang J; Wang S
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188564. PubMed ID: 33974950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment.
    Tian X; Shen H; Li Z; Wang T; Wang S
    J Hematol Oncol; 2019 Aug; 12(1):84. PubMed ID: 31438991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.